★ Daily Intelligence Briefings (DIBs)MarketsPolitics & Policy Cannabis Legalization Approved in Two States, But Still Likely to Remain Low Priority in Congress Cannabis was on the ballot in five US states yesterday as part of the 2022 midterm elections. Of those five,…McAlinden Research PartnersNovember 9, 2022
★ Daily Intelligence Briefings (DIBs)MarketsServicesTechnology Starlink Set to Compete with Satellite Internet Mainstays and Fellow Newcomers in Bid for In-Flight Internet Starlink's new internet service for private jets promises faster speeds than its competitors who have been in the business much…McAlinden Research PartnersOctober 20, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene EditingⓁ PharmaceuticalsMarkets Pharma Fires Up More M&A Deals in Genetic Medicine as First CRISPR Drug Moves Closer to Commercialization Mergers and Acquisitions in the biopharma space continue to heat up, fueling a significant increase in large deals through the first 9…McAlinden Research PartnersOctober 19, 2022
★ Daily Intelligence Briefings (DIBs)MarketsTechnology Fallout From Ethereum “Merge” Bolsters Bitcoin’s Hash Rate as Some Criticisms Still Linger A month on from Ethereum's (ETH) highly-anticipated "Merge", the network has proven to be quite resilient since making the jump…McAlinden Research PartnersOctober 18, 2022
★ Daily Intelligence Briefings (DIBs)MarketsPolitics & PolicyServices Sports Betting’s Costly Quest for California Crumbles, But ESPN-DraftKings Partnership Breaks New Ground DraftKings is reportedly in talks for an unprecedented partnership with ESPN, the most recognizable name in sports broadcasting. That is…McAlinden Research PartnersOctober 12, 2022
⚑ Joe Mac's ViewpointsCommoditiesEconomics & TradeMarketsMonetary Policy The “Real” Rate Story Rising nominal rates are clearly putting pressure on economic growth in the US. The Fed has become more aggressive as…McAlinden Research PartnersOctober 4, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene EditingMarkets CRISPR Tech Closes in on First FDA Approval, New Treatment Methods Continue to Emerge The US's first marketed CRISPR drug may be set to make its debut in a year or less, following CRISPR…McAlinden Research PartnersSeptember 29, 2022
★ Daily Intelligence Briefings (DIBs)Economics & TradeMarketsMonetary PolicyPolitics & Policy UK’s Pound Sterling Slammed by Stagflationary Prospects, Loss of Confidence in Policymakers The UK's Pound Sterling (GBP) plummeted yesterday, recording one of its worst days of trading across the past three decades. Moreover,…McAlinden Research PartnersSeptember 27, 2022
★ Daily Intelligence Briefings (DIBs)CommoditiesMarkets Vertical Farming Could Shore up Future Food Security as the World Faces Drought and Instability Vertical farming is widely viewed as the preeminent form of indoor farming, maximizing water-efficiency and aiding the management of other…McAlinden Research PartnersSeptember 7, 2022
★ Daily Intelligence Briefings (DIBs)Labor, Education & DemographicsMarketsTechnology “Work From Home” Trade Fades, Now Facing Watershed Moment With Potential Recession Looming The glow of Zoom and other stocks that boomed on the "work from home" trade has faded in 2022 amid a…McAlinden Research PartnersAugust 23, 2022